Support program for lung cancer patients awaiting scan results
Official title: Support for Cancer Patients Awaiting News (SCAN Study): Pilot Testing a Stress Management Program
Run by Hackensack Meridian Health · NCT06199570 · Data updated 2026-11-12
This study is testing a stress management program for advanced lung cancer patients to see if it helps them feel less anxious while waiting for scan results.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 1 site (Hackensack, New Jersey) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | August 4, 2026 |
| Trial ID | NCT06199570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with Stage III-IV lung cancer who experience appointment- or scan-related stress.
✕Probably not a fit
Patients with severe psychiatric illnesses or those currently enrolled in hospice may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This behavioral intervention aims to pilot test a stress management program specifically designed for patients with advanced lung cancer who are undergoing routine scans. The study consists of two phases: an Open Trial phase to assess feasibility and gather feedback, followed by a Pilot Randomized Controlled Trial phase to evaluate the intervention's acceptability and preliminary effects on anxiety. The program includes psychoeducation and stress management activities delivered through a web platform, tailored to help patients cope with anxiety while waiting for scan results. The goal is to improve quality of life during a challenging time for these patients.
Why it matters
Potential benefit: If successful, this program could significantly reduce anxiety and improve the quality of life for lung cancer patients awaiting scan results.
How similar studies have gone: Other studies have shown promise in using stress management interventions for cancer patients, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult (ages 18 and older) 2. Comfortable speaking, reading, and writing English without an interpreter 3. Established diagnosis of lung cancer (3a. Open Trial phase only: Stage III-IV lung cancer or extensive stage small cell lung cancer) 4. ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 2 5. Receiving ongoing care from collaborating clinics with regular scans 6. Receiving systemic treatment for lung cancer 7. Endorse at least mild anxiety (using the PROMIS Anxiety 4a) or appointment- or scan-related stress on 4-item screen (using a modified Distress Thermometer item, a Fear of Progression scale item, an Impact of Events scale item, and an item from our prior study) 8. Willingness to use the study website Exclusion Criteria: 1. Moderate-to-severe cognitive impairment (per dementia diagnosis or cognitive screen) 2. Requires an interpreter for medical visits 3. Severe psychiatric illness (psychiatric hospitalization in the past year, or substance use disorder, bipolar disorder, or psychosis diagnosis) 4. Currently enrolled in hospice 5. Unable to complete study activities per oncology provider's judgment (e.g., due to fatigue)
Where it's running
-
Amanda Khoudary
Hackensack, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Heather Derry-Vick, PhD — Hackensack Meridian Health
- Study coordinator: Amanda Khoudary, BA
- Email: Amanda.Khoudary@hmh-cdi.org
- Phone: 2018803445
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.